Intercalation of Pharmorubicin Anticancer Drug to DNA Studied by Cyclic Voltammetry with Analytical Applications
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Analytical Letters
- Vol. 32 (4) , 717-727
- https://doi.org/10.1080/00032719908542851
Abstract
Variations of the cyclic voltammetric behavior of pharmorubicin in an aqueous medium upon addition of DNA were studied and utilized for the determination of DNA. It was observed that the redox waves of pharmorubicin after binding to the large and slowly diffusing DNA almost disappeared. The anodic peak currents of pharmorubicin, when the concentrations were fixed at 2.0 x 10−5 and 2.0 x 10−4 mol/L, decreased linearly correlated to the concentration of DNA added in the range of 0 - 30.7 and 0 - 260.3 μg/ml, with the detection limits of 1.2 and 20.8 μg/ml, respectively. The proposed method exhibited good recovery and reproducibility for the determination of DNA. Furthermore, the binding constant and binding site size of the pharmorubicin-DNA interaction were also calculated.Keywords
This publication has 4 references indexed in Scilit:
- Platinum Anticancer Drug Binding to DNA Detected by Thickness-Shear-Mode Acoustic Wave SensorAnalytical Chemistry, 1995
- Platinum DNA intercalator-mononucleotide adduct formation. Cooperativity between aromatic ring stacking and electrostatic interactionsInorganic Chemistry, 1991
- Bis-9-acridinyl derivative containing a viologen linker chain: electrochemically active intercalator for reversible labelling of DNAJournal of the Chemical Society, Chemical Communications, 1990
- Voltammetric studies of the interaction of tris(1,10-phenanthroline)cobalt(III) with DNAJournal of the American Chemical Society, 1987